Hematopoietic Progenitor Cells and The Treatment of Malignant Diseases

Introduction Proper handling, storage, and selection of transplantation hematopoietic progenitor cells (HPC) products is important to maintain product survival and reduce the potential for harmful receptor reactions. Hematopoietic progenitor cells are most commonly used for the treatment of various blood diseases. Several non-malignant diseases can also be treated with HPC transplant, but this is rare because of the high risk of fatal complications associated with surgery.

Hematopoietic stem cell transplantation has become the standard treatment for many diseases in children and adults. Allogeneic hematopoietic stem cells have three origins, bone marrow, peripheral blood, umbilical cord blood. Using the burden - benefits Calculations from the perspective of the donor and the recipient, this statement will consider the problem a minor has when they are hematopoietic stem cells, the most common siblings. The statement states that certain conditions must be met in order for minors to act as donors. We also considered what should be included in the informed consent process, including the role of donor supporters.

Detailed studies have revealed the hematopoietic pathways shown in Figures 24-8. Under appropriate conditions, stem cells within the bone marrow will divide and form two types of cells. It is a progenitor cell involving another stem cell and lineage. The latter cells may be referred to as burst forming units (BFU) and colony forming units (CFU), as each cell forms clones (ie colonies) of differentiated cells after several divisions. Many extracellular factors called cytokines are essential for the formation of progenitor cells involved in the lineage and subsequent proliferation and differentiation of these cells. Many of these cytokines are secreted by stromal cells in the bone marrow or are secreted to the surface of these cells. Several such as SCF, IL - 3 or GM - CSF support proliferation and differentiation of progenitor cells of many blood cell types. Others such as Epo play a major role in the ancestry of a single lineage.

This alternative to hematopoietic stem cells is called allogeneic hematopoietic stem cell transplantation. Similarly, bone marrow transplantation, also known as stem cell transplantation, is the process of replacing diseased or damaged bone marrow cells with healthy bone marrow cells. In extreme cases, procedures are undertaken where the patient is undergoing high dose chemotherapy or radiotherapy. Conditions successfully treated with the aid of bone marrow transplantation include various types of blood related cancers such as leukemia, lymphoma, multiple myeloma and solid tumor, aplastic anemia